InsidersTradesSigma
Track the Embecta Corp. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, Embecta Corp. has published 104 reports. Market capitalisation: €276.5m. The latest transaction was filed on 13 August 2026 (Acquisition). Among the most active insiders: Kurdikar Devdatt. All data is free.
104
Insider Decl.
n/a
Thresholds
€1m
13 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Embecta Corp. Hold (neutral), based on 2 analysts. Average price target: US$4.00.
40Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 2,738 of 28,985 companies
74.4
score / 100
Value94
Quality55
FCF yld64%
Earn yld33%
EV/EBITDA6.0x
ROE·
Gross mgn63%
Net mgn8.8%
Debt/EBITDA5.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 August 2026
Declarations104 total
20,000 shares@ US$4.668Common StockSEC:0000947871-26-000788:0
Canonical exit: 10 Nov 2026 (T+90)
45,000 shares@ US$4.9744Common StockSEC:0000947871-26-000786:0
Canonical exit: 10 Nov 2026 (T+90)
20,000 shares@ US$4.99Common StockSEC:0000947871-26-000787:0
Canonical exit: 10 Nov 2026 (T+90)
30,000 shares@ US$4.6979Common StockSEC:0000947871-26-000789:0
Canonical exit: 10 Nov 2026 (T+90)
1,480 shares@ US$4.420.0033% mcap20.1% of flowCommon StockSEC:0000947871-26-000779:0
22,841 shares0Common StockSEC:0000947871-26-000165:0
22,841 shares0Common StockSEC:0000947871-26-000164:0
22,841 shares0Common StockSEC:0000947871-26-000163:0
22,841 shares0Common StockSEC:0000947871-26-000162:0
22,841 shares0Common StockSEC:0000947871-26-000161:0
22,841 shares0Common StockSEC:0000947871-26-000160:0
32,817 shares0Common StockSEC:0000947871-25-001053:0
38,783 shares0Common StockSEC:0000947871-25-001052:0
79,555 shares0Common StockSEC:0000947871-25-001051:0
288,386 shares0Common StockSEC:0000947871-25-001050:0
95,466 shares0Common StockSEC:0000947871-25-001049:0
37,789 shares0Common StockSEC:0000947871-25-001048:0
916 shares@ US$12.2842.7% of flowCommon StockSEC:0000947871-25-000735:0
10,000 shares@ US$10.599516.3% of flowCommon StockSEC:0000947871-25-000561:0
Canonical exit: 21 Aug 2025 (T+90)
5,285 shares@ US$12.0038.2% of flowCommon StockSEC:0000947871-25-000368:0
3,249 shares@ US$12.0060.4% of flowCommon StockSEC:0000947871-25-000369:0
39,592 shares@ US$12.0038.0% of flowCommon StockSEC:0000947871-25-000367:0
4,948 shares@ US$12.0029.1% of flowCommon StockSEC:0000947871-25-000370:0
13,000 shares@ US$13.665129.5% of flowCommon StockSEC:0000947871-25-000221:0
Canonical exit: 26 May 2025 (T+90)
13,839 shares0Common StockSEC:0000947871-25-000185:0
25 of 104 declarations
About Embecta Corp.
Embecta Corp. is a company focused on the healthcare and pharmaceutical sector, specializing in diabetes management solutions. It is listed on NASDAQ under the ticker EMBecta.